← Our News

Research & clinical trials, Charity news & media, Policy & advocacy

The questions that matter most: Top 10 neuroendocrine cancer research priorities agreed

By Beth Chesser

Posted 4 months ago

10/07/2026 3pm

Listen to this article

“For the first time since my diagnosis, I felt I was no longer just navigating the system – I was helping to shape its future.” 

This week marked a significant milestone for the neuroendocrine cancer community as people living with neuroendocrine cancer, carers and healthcare professionals came together to agree the Top 10 research priorities through the James Lind Alliance (JLA) Priority Setting Partnership. 

The final workshop brought together individuals with different perspectives but a shared goal: to ensure future research focuses on the questions that matter most to those affected by neuroendocrine cancer. 

The agreed Top 10 research priorities are the culmination of a rigorous and inclusive process. It began with a national survey inviting people affected by neuroendocrine cancer, their carers, and the healthcare professionals who support them to submit the unanswered questions they felt future research should address. More than 1,000 questions were received, reviewed, and refined into a shortlist. This shortlist was then prioritised through a second national survey before being discussed at the final James Lind Alliance workshop, where people with lived experience, carers, and clinicians worked together as equal partners to agree the final Top 10 priorities. 

We would like to thank everyone who has contributed to the Priority Setting Partnership. From those who submitted questions in the initial survey to everyone who participated in the workshops, your experiences, expertise and willingness to work together have made this possible. 

The final Top 10 priorities will provide an important roadmap helping to focus future investment on the areas that will make the greatest difference to people affected by neuroendocrine cancer. 

Proud to have been part of shaping the future of neuroendocrine cancer research 

Yesterday, I had the privilege of attending a priority-setting workshop at the Royal College of Surgeons of England in London, working alongside the James Lind Alliance and Neuroendocrine Cancer UK to identify and prioritise the most important unanswered questions in neuroendocrine cancer.

Throughout the day, we worked in both small and large groups, sharing experiences, listening to different perspectives, and collaboratively setting priorities that have the potential to shape future research.

For the neuroendocrine cancer community, this work is incredibly important. Ensuring that people with lived experience are at the heart of research priorities means that the questions which matter most to patients, families, carers, and clinicians can help shape the future of treatment, care, and outcomes.

It was a genuine pleasure to be part of such an inspiring day. Bringing together patients, carers, healthcare professionals, and researchers to openly share experiences and ideas demonstrated the power of collaboration and the value of every voice in the room. 

Again, a huge thank you to the James Lind Alliance , Neuroendocrine Cancer UK , and everyone who contributed to such meaningful discussions. I’m proud to have been involved and excited to see how yesterday’s work helps drive the future of neuroendocrine cancer research 

David Corbin 

 

To see the full list of priorities click here Neuroendocrine Cancer | NIHR JLA   

Catch up on the latest news, stories and updates

Angela

Patient Ambassador

Angela became an Ambassador in 2026.